News
We are pleased to announce our latest news to you.

Conference: Patient Engagement: patient's role in the development process of MedTech companies
The inclusion of patient experience and expertise throughout the product lifecycle is key to delivering compelling, patient-oriented and innovative products and services. Patient engagement is also becoming increasingly important from a regulatory and reimbursement perspective, as well as in rehabilitation.

Patient Engagement Guide Alert: New Case Study online!
Claudia and Ilona Brandt are twin sisters. They are SMA (spinal muscular atrophy) patients and founders of the SMArty-Symposium in Germany. Through their disease, they regularly observe unmet needs and optimization potentials for their medical aids and other treatment and care related technologies.
Read more … Patient Engagement Guide Alert: New Case Study online!

The new Patient Engagement Guide (PEG) is out now: Get free access!
admedicum and HollandBIO presented the Patient Engagement Guide (PEG) at this year’s Dutch Biotech Event on June 29 in Utrecht, NL.
Read more … The new Patient Engagement Guide (PEG) is out now: Get free access!

Results of a Pharma-Patient Meeting
admedicum recently moderated another pharma-patient forum about "Patient Engagement in pharmaceutical R&D“. Our client, a pharmaceutical company, invited advocates from a number of German patient groups, both for common and rare diseases. Joint working groups facilitated an exchange mainly on expectations, suggestions, and concerns on behalf of the patient advocates with regard to collaboration with the company.

admedicum welcomes Maryze Schoneveld van der Linde as a new expert in its team!
We are delighted to announce that admedicum has the honor to call Maryze Schoneveld van der Linde a new Strategic Partner! Maryze, is a rare disease advocate and expert by experience regarding drug development, active patient involvement from the patient perspective, empowerment related issues and building networks. Maryze is a Pompe patient bound to wheelchair and thus has been advocating the actual real life experience of patients at many international conferences, events and company patient engagement initiatives.
Read more … admedicum welcomes Maryze Schoneveld van der Linde as a new expert in its team!

admedicum welcomes Rachel Jones as a new expert in its team!
We are delighted to announce that admedicum has today welcomed a new Associate Partner to its team. Rachel Jones who is UK based, is former global Global Patient Centricity Lead at Astra Zeneca and experienced Patient Engagement Expert. She is a welcome member of our growing International consultancy team which aims to connect Pharmaceutical companies with patients in order to deliver the best solutions for all. Rachel has over a decades ...
Read more … admedicum welcomes Rachel Jones as a new expert in its team!

Patient Engagement as a key to making Drug Development more successful and efficient
Nancy Meyerson-Hess about the benefits of patient engagement in R&D in the latest ClinicalTrialsArena article. Nancy Meyerson-Hess, BA, MPhil, discusses the benefits of patient engagement in R&D Patient engagement, a strong term, but what does it really mean?
Read more … Patient Engagement as a key to making Drug Development more successful and efficient

admedicum welcomes Nancy Meyerson-Hess as a new expert in its team!
We are very happy about welcoming Nancy Meyerson-Hess as a new Associate Partner of admedicum® Business for Patients.
Nancy Meyerson-Hess has over 30 years of experience in clinical research. She has led global teams of clinical research professionals within pharmaceutical and contract research organizations.
Read more … admedicum welcomes Nancy Meyerson-Hess as a new expert in its team!

Pharma Relations 04/2017: Dr. Andreas Reimann in an interview
Dr. Andreas Reimann in an interview with Pharma Relations about patient orientation in pharmaceutical companies.
In the current edition of Pharma Relations 04/2017, the leading magazine for Pharma-Marketing and Healthcare Communication, Dr. Andreas Reimann talks about patient orientation in pharmaceutical companies.
Patient-access to new RD therapies
Some key questions arising from the 2nd multi-stakeholder symposium on improving patient access to rare-disease therapies February 22 and 23, 2017, Brussels, Belgium